Parexel opens clinical logistics facilities in Singapore and Russia

The company’s new depot in Singapore and ancillary warehouse in Russia will support its clients in more effectively managing their global clinical trial supply requirements.

Both facilities serve as an extension of Parexel’s existing infrastructure of depots and ancillary warehouses based throughout North America, Latin America, Europe and Africa, as well the Asia/Pacific region.

With one of the largest and most comprehensive clinical research organisations in Eastern Europe and the Asia/Pacific region, the new facilities further strengthen Parexel’s ability to meet the Clinical Logistics Services needs of its clients.

The new depot in Singapore handles the distribution of investigational medicinal products and non-investigational medicinal products, as well as ancillary supplies needed for clinical trials conducted by Parexel.

The new ancillary warehouse in Russia is intended to store any non-drug material required for clinical trials in Russia, including lab kits, drug application material, and medical supplies and equipment, as well as documents, such as patient diaries and questionnaires.

Both new facilities feature 24/7 monitoring systems, and provide a number of services to clients, including inventory management, as well as return and destruction capabilities.

Joe Avellone, managing director & corporate vice president of Clinical Research Services at Parexel said: "The depot in Singapore, which is a leading logistics hub for the Asia/Pacific region, with best-in-class transportation performance and favourable import/export regulations, will help us to more easily service countries throughout Asia for our clients."